Heidi Tiller - Gynecology

Author Information

Heidi Tiller is affiliated with the Immunology Research Group at the Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway. She also holds a position in the Department of Obstetrics and Gynecology at the University Hospital of North Norway, Tromsø, Norway. Her research primarily focuses on immunology and gynecology, with a significant interest in platelet alloimmunization and its effects on pregnancy.

Research Contributions

Heidi Tiller has made substantial contributions to the understanding of platelet alloimmunization and its impact on pregnancy outcomes. Her work includes the study of chronic intervillositis, fetal and neonatal alloimmune thrombocytopenia, and the role of maternal antibodies in fetal development. She has authored noteworthy papers on these topics, exploring the clinical implications and potential treatment opportunities for conditions such as chronic histiocytic intervillositis and alloimmune thrombocytopenia.

Aliases

Heidi Tiller is also known by the following aliases: H Tiller, H. Tiller, and Heidi Tiller.

Publication and Citation Metrics

Metric	Value
Citation Count	565
h-index	12
Paper Count	37

Publications:

When platelet alloimmunization meets chronic intervillositis: A prospective histopathology study suggests increased severity of clinical outcome

DOI: 10.1016/J.PLACENTA.2021.07.246

Year: 2021

Platelet alloimmunization is associated with low grade chronic histiocytic intervillositis - A new link to a rare placental lesion?

DOI: 10.1016/j.placenta.2021.07.291

Year: 2021

A combined effect of anti‐HPA‐1a and anti‐HLA Class I in pregnancy?

DOI: 10.1111/trf.15944

Year: 2020

Fetal and neonatal alloimmune thrombocytopenia - The Norwegian management model.

DOI: 10.1016/j.transci.2019.102711

Year: 2019

A pregnant woman with pancytopenia.

DOI: 10.4045/tidsskr.19.0022

Year: 2019

Chronic intervillositis linked to platelet alloimmunization – a new entry port to understanding a rare but important placental lesion

DOI: 10.1016/j.placenta.2019.06.136

Year: 2019

Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study

DOI: 10.1371/journal.pone.0182957

Year: 2017

Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities

DOI: 10.2147/IJWH.S90753

Year: 2017

Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model

DOI: 10.1186/s12958-017-0245-6

Year: 2017

Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.

DOI: 10.1016/j.jri.2017.06.003

Year: 2017

Can Alendronate be Used in Combination with Other Therapies?

What Role Does the Gut Play in Detoxification?

How Can Healthcare Providers Prevent Infections During Procedures?

What are Microcalcifications?

What is Enhanced Coordination in Gynecology?

What are the latest advancements in gynecological testing methods?

What Are the Benefits of Multidisciplinary Teams?

What advanced technologies are used in gynecological diagnostics?

What causes abnormal bleeding?

How are Reproductive Health Issues Diagnosed?

Partnered Content Networks

Relevant Topics